title: Urologic experience in 48 heart transplant recipients.
abstract: BACKGROUND
  Urologic experience in heart transplant recipients as a population group has not been reported.
  
  
  METHODS
  We reviewed the charts of 48 consecutive heart transplant recipients who were evaluated and treated in our outpatient urologic clinic. Patients were treated for various urologic conditions by both medical and surgical means.
  
  
  RESULTS
  No major complications were encountered.
  
  
  CONCLUSIONS
  Heart transplant recipients may be treated with minimal morbidity; thus, their urologic complaints should be addressed and treated with confidence.
authors.affiliation: Department of Urology, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, La, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Donaldson
authors.forename: H A
authors.initials: HA
authors.lastname: Fuselier
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000601:surgery; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases; D008875:Middle Aged; D010409:Penile Diseases / Q000188:drug therapy / Q000382:microbiology; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011472:Prostatitis / Q000188:drug therapy; D012189:Retrospective Studies; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D000317:Adrenergic alpha-Antagonists